Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement

Environmental and Heritable Factors in the Causation of Cancer — Analyses of Cohorts of Twins from Sweden, Denmark, and Finland

2000 • 4,020 citations

Mortality Results from a Randomized Prostate-Cancer Screening Trial

2009 • 2,828 citations

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

2016 • 2,414 citations

Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement

2012 • 2,379 citations

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

2014 • 1,451 citations

Early Detection of Prostate Cancer: AUA Guideline

2013 • 1,192 citations

Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer

2016 • 1,147 citations

Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer

2014 • 904 citations

Annual Report to the Nation on the Status of Cancer, 1975‐2012, featuring the increasing incidence of liver cancer

2016 • 896 citations

Trends in Management for Patients With Localized Prostate Cancer, 1990-2013

2015 • 579 citations

Follow-up of Prostatectomy versus Observation for Early Prostate Cancer

2017 • 542 citations

Prevention and early detection of prostate cancer

2014 • 442 citations

Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program

2002 • 401 citations

Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC)

2012 • 258 citations

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study

2012 • 250 citations

The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate‐specific Antigen‐era

2014 • 244 citations

Extended mortality results for prostate cancer screening in the PLCO trial with median follow‐up of 15 years

2016 • 216 citations

Recommendations on screening for prostate cancer with the prostate-specific antigen test

2014 • 198 citations

Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial

2010 • 141 citations

Prostate Cancer Mortality in the Finnish Randomized Screening Trial

2013 • 109 citations

The effect of study arm on prostate cancer treatment in the large screening trial ERSPC

2009 • 94 citations

The impact of a suspicious prostate biopsy on patients’ psychological, socio-behavioral, and medical care outcomes

2006 • 78 citations

False-positive screening results in the European randomized study of screening for prostate cancer

2011 • 68 citations

Health Perceptions in Patients Who Undergo Screening and Workup for Prostate Cancer

2007 • 60 citations

Measuring the psychosocial impact of population‐based prostate‐specific antigen testing for prostate cancer in the UK

2006 • 50 citations

Impact of Family History on Prostate Cancer Mortality in White Men Undergoing Prostate Specific Antigen Based Screening

2014 • 45 citations

Five-Year Downstream Outcomes Following Prostate-Specific Antigen Screening in Older Men

2013 • 32 citations